Mark Edward Schnute,Andrew Christopher Flick,Peter Jones,Neelu Kaila,Scot Richard Mente,John David Trzupek,Michael L. Vazquez,Göran Mattias Wennerstål,Li Xing,Edouard Zamaratski,Liying Zhang
申请号：
US14864840
公开号：
US09670201B2
申请日:
2015.09.24
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention provides methyl- and trifluoromethyl-substituted pyrrolopyridines, pharmaceutical compositions thereof, methods of modulating RORγ activity and/or reducing the amount of IL-17 in a subject, and methods of treating various medical disorders using such pyrrolopyridines and pharmaceutical compositions thereof.
